AZEBONE (Risedronate Sodium) 35mg Tablets

DRUG CATEGORY: Bisphosphonates /Bone Metabolism Regulator

MECHANISM OF ACTION: Inhibits osteoclast mediated bone resorption and modulates bone metabolism. Risedronate treatment reduces bone turnover (i.e., activation frequency, the rate at which bone remodelling sites are activated) and bone resorption at remodelling sites.

INDICATIONS: Postmenopausal Osteoporosis, Treatment of Osteoporosis, Prevention of Osteoporosis , Glucocorticoid-Induced Osteoporosis, Paget’s Disease

DOSAGE AND ADMINISTRATION:  Adult: 35mg once a week on the same day each week. Swallow whole in an upright position, with plain water, at least 30 minutes before the first food, other medicines or drink of the day. Children: Not recommended.

PRESENTATION: Azebone 35mg Tablets are present in Alu-Alu Blister pack of 1×4’s Tablets.